Retatrutide is a newly developed drug that acts as a powerful GLP-1 receptor activator. This revolutionary treatment holds significant promise for controlling type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide boosts insulin secretion and limits glucagon release, leading to improved blood sugar control. Clinical trials have dem